À retenir
This review included 23 studies of mobile health (mHealth) nutrition interventions in adults with chronic kidney disease; the 8 eligible for meta-analysis showed no significant effects on biochemical outcomes or interdialytic weight gain in people on dialysis. Improvements reported by pre-post studies, with no control group, cannot be credited to the apps.
Study design
Revue des preuves
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Kidney disease diets are complicated and hard to fit into daily life, and phone-based tools could help with education and self-monitoring. The authors reviewed whether mHealth interventions improve nutrition-related and clinical outcomes in adults with chronic kidney disease (CKD).
Population et méthode
Systematic review and meta-analysis following PRISMA guidelines. Five databases were searched from inception through February 2026. Controlled trials, quasi-experimental designs and pre-post studies of mHealth interventions reporting nutrition-related or clinical outcomes were eligible. Randomized controlled trials and controlled quasi-experimental studies with comparable outcomes were pooled, while pre-post studies were summarised narratively because changes could not be separated from the passage of time. Risk of bias used the Cochrane Risk of Bias tool and ROBINS-I.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 123 studies were included in the review, and 8 met the criteria for meta-analysis.
- 2In the pooled analysis of adults on dialysis, there were no significant effects on biochemical outcomes or interdialytic weight gain.
- 3Several pre-post studies reported within-study improvements in dietary intake, including sodium intake, and in blood pressure outcomes, but without a concurrent control group these cannot be attributed to the mHealth intervention.
- 4The authors conclude that mHealth may support selected dietary and clinical outcomes, while evidence from randomized controlled trials remains limited.
Limites et incertitude
- 1Only 8 of 23 studies could be pooled, and the abstract does not give pooled effect sizes, confidence intervals or the number of participants.
- 2The pre-post studies that showed improvements had no comparison group, so the benefit they suggest may reflect time or attention.
- 3The pooled results concern adults on dialysis; the abstract does not report separate pooled results for earlier-stage CKD.
- 4The abstract does not report the types of apps or the intervention length, and it does not rate evidence certainty; this reading is based on the abstract only.
Mise en perspective
Diet apps or text-based coaching might help some people with kidney disease follow their plan, but this review found no proven effect on blood tests or fluid gain in the pooled trials. Any dietary change in kidney disease, particularly around sodium, potassium or fluid, should be set with a kidney dietitian or nephrologist.
Vos données
If you use an app to log meals, sodium or fluid intake, keep using one consistent app and record the same details each day. With a home blood pressure cuff, measure under the same conditions and look at weekly averages, and bring the logs to your kidney team.
Comprendre ce type de preuve
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background/objectives
Diet recommendations for individuals with chronic kidney disease (CKD) are complex and can be challenging to integrate into daily routines. Mobile health (mHealth) interventions may support dietary education, self-monitoring, and disease management; however, their effects on nutrition-related and clinical outcomes in CKD remain unclear. This systematic review and meta-analysis evaluated the effectiveness of mHealth interventions on nutrition-related and clinical outcomes among adults with CKD.
Methods
The review was conducted according to the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines. Five databases were searched from inception through February 2026. Controlled trials, quasi-experimental designs and pre-post studies evaluating mHealth interventions and reporting nutrition-related and/or clinical outcomes were eligible for inclusion. Randomized controlled trials and controlled quasi-experimental studies with comparable outcomes and sufficient data were included in the quantitative synthesis. Pre-post studies were synthesized narratively because changes from baseline could not be distinguished from temporal effects in the absence of a concurrent comparator. Risk of bias was assessed using the Cochrane Risk of Bias tool and ROBINS-I.
Results
Twenty-three studies were included in the review, with eight meeting the inclusion criteria for a meta-analysis. Among the quantitative synthesis of adults on dialysis, no significant effects were shown with biochemical outcomes or interdialytic weight gain. Several pre-post studies reported within-study improvements in dietary intake, including sodium intake, and blood pressure outcomes. These findings should be interpreted cautiously because the absence of a concurrent control group precludes attributing observed changes specifically to the mHealth intervention.
Conclusions
mHealth interventions may support improvements in selected dietary and clinical outcomes among adults with CKD; however, evidence from randomized controlled trials remains limited. Improvements reported in pre/post studies should be interpreted cautiously and additional well-designed randomized controlled trials are needed to determine their effectiveness across CKD populations.
Sources et attribution
Effectiveness of mHealth Nutrition Interventions on Nutrition-Related and Clinical Outcomes in Adults with Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Walter-Cano S, Lee A, Andrade JM.
Nutrients · 2026-10-13
DOI: 10.3390/nu18203357 ↗PubMed · 42942928 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

